Row:Assets
		Row:Current assets:
		Row:Cash and cash equivalents 	$ 16,701 	$ 18,498
Row:Marketable securities 	92,439 	101,177
Row:Total cash, cash equivalents, and marketable securities 	109,140 	119,675
Row:Accounts receivable, net of allowance of $729 and $753 	20,838 	25,326
Row:Income taxes receivable, net 	355 	2,166
Row:Inventory 	1,107 	999
Row:Other current assets 	4,236 	4,412
Row:Total current assets 	135,676 	152,578
Row:Non-marketable investments 	13,859 	13,078
Row:Deferred income taxes 	737 	721
Row:Property and equipment, net 	59,719 	73,646
Row:Operating lease assets 	0 	10,941
Row:Intangible assets, net 	2,220 	1,979
Row:Goodwill 	17,888 	20,624
Row:Other non-current assets 	2,693 	2,342
Row:Total assets 	$ 232,792 	$ 275,909
Row:Liabilities and Stockholders’ Equity
		Row:Liabilities and Stockholders’ Equity
		Row:Current liabilities:
		Row:Accounts payable 	$ 4,378 	$ 5,561
Row:Accrued compensation and benefits 	6,839 	8,495
Row:Accrued expenses and other current liabilities 	16,958 	23,067
Row:Accrued revenue share 	4,592 	5,916
Row:Deferred revenue 	1,784 	1,908
Row:Income taxes payable, net 	69 	274
Row:Total current liabilities 	34,620 	45,221
Row:Long-term debt 	4,012 	4,554
Row:Deferred revenue, non-current 	396 	358
Row:Income taxes payable, non-current 	11,327 	9,885
Row:Deferred income taxes 	1,264 	1,701
Row:Operating lease liabilities 	0 	10,214
Row:Other long-term liabilities 	3,545 	2,534
Row:Total liabilities 	55,164 	74,467
Row:Commitments and Contingencies (Note 10)
		Row:Stockholders’ equity:
		Row:Convertible preferred stock, $0.001 par value per share, 100,000 shares
authorized; no shares issued and outstanding 	0 	0
Row:Class A and Class B common stock, and Class C capital stock and
additional paid-in capital, $0.001 par value per share: 15,000,000 shares
authorized (Class A 9,000,000, Class B 3,000,000, Class C 3,000,000);
695,556 (Class A 299,242, Class B 46,636, Class C 349,678) and
688,335 (Class A 299,828, Class B 46,441, Class C 342,066) shares
issued and outstanding 	45,049 	50,552
Row:Accumulated other comprehensive loss 	(2,306) 	(1,232)
Row:Retained earnings 	134,885 	152,122
Row:Total stockholders’ equity 	177,628 	201,442
Row:Total liabilities and stockholders’ equity 	$ 232,792 	$ 275,909
Row:Accumulated other comprehensive loss 	(2,306) 	(1,232)
Row:Retained earnings 	134,885 	152,122
Row:Total stockholders’ equity 	177,628 	201,442
Row:Total liabilities and stockholders’ equity 	$ 232,792 	$ 275,909
Row:	2017 	2018 	2019
Row:Revenues 	$ 110,855 	$ 136,819 	$ 161,857
Row:Costs and expenses:
			Row:Cost of revenues 	45,583 	59,549 	71,896
Row:Research and development 	16,625 	21,419 	26,018
Row:Sales and marketing 	12,893 	16,333 	18,464
Row:General and administrative 	6,840 	6,923 	9,551
Row:European Commission fines 	2,736 	5,071 	1,697
Row:Total costs and expenses 	84,677 	109,295 	127,626
Row:Income from operations 	26,178 	27,524 	34,231
Row:Other income (expense), net 	1,015 	7,389 	5,394
Row:Income before income taxes 	27,193 	34,913 	39,625
Row:Provision for income taxes 	14,531 	4,177 	5,282
Row:Net income 	$ 12,662 	$ 30,736 	$ 34,343
Row:Basic net income per share of Class A and B common stock and Class
			Row:C capital stock 	$ 18.27 	$ 44.22 	$ 49.59
Row:Diluted net income per share of Class A and B common stock and
			Row:Basic net income per share of Class A and B common stock and Class
Row:C capital stock $ 18.27 $ 44.22 $ 49.59
Row:Diluted net income per share of Class A and B common stock and
Row:Class C capital stock $ 18.00 $ 43.70 $ 49.16
Row:Net income 	$ 12,662 $ 	30,736 	$ 34,343
Row:Other comprehensive income (loss):
			Row:Change in foreign currency translation adjustment 	1,543 	(781) 	(119)
Row:Available-for-sale investments:
			Row:Change in net unrealized gains (losses) 	307 	88 	1,611
Row:Less: reclassification adjustment for net (gains) losses included
in net income 	105 	(911) 	(111)
Row:Net change (net of tax effect of $0, $156, and $221) 	412 	(823) 	1,500
Row:Cash flow hedges:
			Row:Change in net unrealized gains (losses) 	(638) 	290 	22
Row:Less: reclassification adjustment for net (gains) losses included
in net income 	93 	98 	(299)
Row:Net change (net of tax effect of $247, $103, and $42) 	(545) 	388 	(277)
Row:Other comprehensive income (loss) 	1,410 	(1,216) 	1,104
Row:Comprehensive income 	$ 14,072 $ 	29,520 	$ 35,447
Row:(545) 		388 		(277)
Row:1,410 		(1,216) 		1,104
Row:$ 14,072 	$ 	29,520 	$ 	35,447
Row:	Shares 	Amount
	Income (Loss)
	Earnings
	Equity Row:Balance as of December 31, 2016 	691,293 	$ 36,307 	$ (2,402) 	$ 105,131 	$ 139,036
Row:Cumulative effect of accounting
change 	0 	0 	0 	(15) 	(15)
Row:Common and capital stock issued 	8,652 	212 	0 	0 	212
Row:Stock-based compensation expense 	0 	7,694 	0 	0 	7,694
Row:Tax withholding related to vesting of
restricted stock units 	0 	(4,373) 	0 	0 	(4,373)
Row:Repurchases of capital stock 	(5,162) 	(315) 	0 	(4,531) 	(4,846)
Row:Sale of interest in consolidated
entities 	0 	722 	0 	0 	722
Row:Net income 	0 	0 	0 	12,662 	12,662
Row:Other comprehensive income (loss) 	0 	0 	1,410 	0 	1,410
Row:Balance as of December 31, 2017 	694,783 	40,247 	(992) 	113,247 	152,502
Row:Cumulative effect of accounting
change 	0 	0 	(98) 	(599) 	(697)
Row:Common and capital stock issued 	8,975 	148 	0 	0 	148
Row:Stock-based compensation expense 	0 	9,353 	0 	0 	9,353
Row:Tax withholding related to vesting of
restricted stock units and other 	0 	(4,782) 	0 	0 	(4,782)
Row:Repurchases of capital stock 	(8,202) 	(576) 	0 	(8,499) 	(9,075)
Row:Sale of interest in consolidated
entities 	0 	659 	0 	0 	659
Row:Net income 	0 	0 	0 	30,736 	30,736
Row:Other comprehensive income (loss) 	0 	0 	(1,216) 	0 	(1,216)
Row:Balance as of December 31, 2018 	695,556 	45,049 	(2,306) 	134,885 	177,628
Row:Cumulative effect of accounting
change 	0 	0 	(30) 	(4) 	(34)
Row:Common and capital stock issued 	8,120 	202 	0 	0 	202
Row:Stock-based compensation expense 	0 	10,890 	0 	0 	10,890
Row:Tax withholding related to vesting of
restricted stock units and other 	0 	(4,455) 	0 	0 	(4,455)
Row:Repurchases of capital stock 	(15,341) 	(1,294) 	0 	(17,102) 	(18,396)
Row:Sale of interest in consolidated
entities 	0 	160 	0 	0 	160
Row:Net income 	0 	0 	0 	34,343 	34,343
Row:Other comprehensive income (loss) 	0 	0 	1,104 	0 	1,104
Row:Balance as of December 31, 2019 	688,335 	$ 50,552 	$ (1,232) 	$ 152,122 	$ 201,442
Row:	2017 	2018 	2019
Row:Operating activities
			Row:Net income 	$ 12,662 	$ 30,736 	$ 34,343
Row:Adjustments:
			Row:Depreciation and impairment of property and equipment 	6,103 	8,164 	10,856
Row:Amortization and impairment of intangible assets 	812 	871 	925
Row:Stock-based compensation expense 	7,679 	9,353 	10,794
Row:Deferred income taxes 	258 	778 	173
Row:(Gain) loss on debt and equity securities, net 	37 	(6,650) 	(2,798)
Row:Other 	294 	(189) 	(592)
Row:Changes in assets and liabilities, net of effects of acquisitions:
			Row:Accounts receivable 	(3,768) 	(2,169) 	(4,340)
Row:Income taxes, net 	8,211 	(2,251) 	(3,128)
Row:Other assets 	(2,164) 	(1,207) 	(621)
Row:Accounts payable 	731 	1,067 	428
Row:Accrued expenses and other liabilities 	4,891 	8,614 	7,170
Row:Accrued revenue share 	955 	483 	1,273
Row:Deferred revenue 	390 	371 	37
Row:Net cash provided by operating activities 	37,091 	47,971 	54,520
Row:Investing activities
			Row:Purchases of property and equipment 	(13,184) 	(25,139) 	(23,548)
Row:Purchases of marketable securities 	(92,195) 	(50,158) 	(100,315)
Row:Maturities and sales of marketable securities 	73,959 	48,507 	97,825
Row:Purchases of non-marketable investments 	(1,745) 	(2,073) 	(1,932)
Row:Maturities and sales of non-marketable investments 	533 	1,752 	405
Row:Acquisitions, net of cash acquired, and purchases of intangible assets 	(287) 	(1,491) 	(2,515)
Row:Proceeds from collection of notes receivable 	1,419 	0 	0
Row:Other investing activities 	99 	98 	589
Row:Net cash used in investing activities 	(31,401) 	(28,504) 	(29,491)
Row:Financing activities
Net payments related to stock-based award activities 	(4,166) 	(4,993) 	(4,765)
Row:Repurchases of capital stock 	(4,846) 	(9,075) 	(18,396)
Row:Proceeds from issuance of debt, net of costs 	4,291 	6,766 	317
Row:Repayments of debt 	(4,377) 	(6,827) 	(585)
Row:Proceeds from sale of interest in consolidated entities 	800 	950 	220
Row:Net cash used in financing activities 	(8,298) 	(13,179) 	(23,209)
Row:Effect of exchange rate changes on cash and cash equivalents 	405 	(302) 	(23)
Row:Net increase (decrease) in cash and cash equivalents 	(2,203) 	5,986 	1,797
Row:Cash and cash equivalents at beginning of period 	12,918 	10,715 	16,701
Row:Cash and cash equivalents at end of period 	$ 10,715 	$ 16,701 	$ 18,498
Row:Supplemental disclosures of cash flow information
			Row:Cash paid for taxes, net of refunds 	$ 6,191 	$ 5,671 	$ 8,203
Row:Purchases of property and equipment 	(13,184) 	(25,139) 	(23,548)
Row:Purchases of marketable securities 	(92,195) 	(50,158) 	(100,315)
Row:Maturities and sales of marketable securities 	73,959 	48,507 	97,825
Row:Purchases of non-marketable investments 	(1,745) 	(2,073) 	(1,932)
Row:Maturities and sales of non-marketable investments 	533 	1,752 	405
Row:Acquisitions, net of cash acquired, and purchases of intangible assets 	(287) 	(1,491) 	(2,515)
Row:Proceeds from collection of notes receivable 	1,419 	0 	0
Row:Other investing activities 	99 	98 	589
Row:Net cash used in investing activities 	(31,401) 	(28,504) 	(29,491)
Row:Financing activities
			Row:Net payments related to stock-based award activities 	(4,166) 	(4,993) 	(4,765)
